Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in mucosal vaccine development.

H Chen1

  • 1AstraZeneca R&D Boston, 128 Sidney Street, 02139, Cambridge, MA 02139, USA. hongming@alum.mit.edu

Journal of Controlled Release : Official Journal of the Controlled Release Society
|May 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adrenocorticotropic hormone-secreting pheochromocytomas: the exception to the rule.

Surgery·1995
Same author

The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha.

The Journal of biological chemistry·1995
Same author

Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium.

Circulation·1995
Same author

Purification of a heteromeric CCAAT binding protein from Neurospora crassa.

Molecular & general genetics : MGG·1995
Same author

Requirement for neuregulin receptor erbB2 in neural and cardiac development.

Nature·1995
Same author

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Proceedings of the National Academy of Sciences of the United States of America·1995
Same journal

Localized pH regulation via a dynamic proton-converting raft for gastroesophageal reflux disease.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Systems engineering of engineered live biotherapeutics: A discovery-to-translation framework for streamlining microbiome therapeutic development.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Endogenous-metabolite-inspired polyamine-oleic acid lipids for safe mRNA delivery and PCSK9 gene editing.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Tunable rigid spikes on virus-like porous silica enable mechanistically controlled nanovaccine platforms.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Metabolic regulation-driven nanoparticles for tumor vulnerabilization and enhanced photodynamic therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles

Developing effective mucosal vaccines requires improving antigen delivery and discovering new adjuvants. Current vaccines are mostly parenteral due to low mucosal absorption and suboptimal immune responses from mucosal delivery.

Area of Science:

  • Immunology
  • Vaccinology
  • Drug Delivery

Background:

  • The mucosal immune system is crucial for protecting body surfaces from pathogens.
  • Current vaccines are primarily administered parenterally due to poor mucosal absorption and inconsistent immune responses.
  • Mucosal immunization often requires adjuvants to elicit sufficient immune responses.

Purpose of the Study:

  • To review recent advancements in mucosal antigen delivery systems.
  • To discuss the development of novel mucosal adjuvants for enhanced vaccine efficacy.
  • To highlight strategies for overcoming challenges in mucosal vaccine development.

Main Methods:

  • Literature review of recent studies on mucosal vaccine delivery and adjuvants.
  • Analysis of current challenges and successes in mucosal immunization.

Related Experiment Videos

  • Discussion of emerging technologies and strategies in the field.

    • Main Results:

    • Low absorption efficiency remains a significant hurdle for mucosally delivered vaccines.
    • Suboptimal immune responses are common with mucosal immunization, necessitating adjuvants.
    • Recent progress has been made in developing improved delivery systems and identifying potential mucosal adjuvants.

    Conclusions:

    • Advancements in antigen delivery and adjuvant discovery are critical for successful mucosal vaccines.
    • Overcoming current limitations will enable the development of more effective vaccines for mucosal surfaces.
    • Further research is needed to translate these advances into broadly applicable mucosal vaccines.